Among the treatment options your doctor can offer, nobody wants the silent treatment. That's what happens when the promise — and expectation — of connected care via telehealth goes unfulfilled. It's a letdown that can be life-threatening for the millions living with heart arrythmias. For those managing their care with our Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices — which have Bluetooth® connectivity and pair with an intuitive myMerlinPulse™ app for Apple and Android™ — they aren't left staring at their phones. 'When we think about traditional remote monitoring, we have a box that sits at the patient's nightstand. The patient has no feedback until they see a light blink. They're not sure what that light means. They have no understanding if the device has been transmitting information,' said Dr. Harish Manyam, chief of cardiology and head of electrophysiology at Erlanger Hospital in Chattanooga, Tenn., the first physician in the U.S. to implant the Gallant device. That's how it was, a reality of yesterday.